Cochlear Ltd Adr Stock Performance
| CHEOY Stock | USD 97.60 1.46 1.52% |
The firm shows a Beta (market volatility) of 0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CochLear's returns are expected to increase less than the market. However, during the bear market, the loss of holding CochLear is expected to be smaller as well. At this point, CochLear ADR has a negative expected return of -0.0461%. Please make sure to confirm CochLear's treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if CochLear ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CochLear Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, CochLear is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 609.6 M | |
| Total Cashflows From Investing Activities | -138.9 M |
CochLear |
CochLear Relative Risk vs. Return Landscape
If you would invest 10,124 in CochLear Ltd ADR on August 26, 2024 and sell it today you would lose (364.00) from holding CochLear Ltd ADR or give up 3.6% of portfolio value over 90 days. CochLear Ltd ADR is currently producing negative expected returns and takes up 1.4457% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than CochLear, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CochLear Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CochLear's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CochLear Ltd ADR, and traders can use it to determine the average amount a CochLear's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0319
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CHEOY |
Estimated Market Risk
| 1.45 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CochLear is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CochLear by adding CochLear to a well-diversified portfolio.
CochLear Fundamentals Growth
CochLear Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CochLear, and CochLear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CochLear Pink Sheet performance.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 9.05 B | |||
| Shares Outstanding | 131.56 M | |||
| Price To Earning | 49.26 X | |||
| Price To Book | 8.15 X | |||
| Price To Sales | 5.55 X | |||
| Revenue | 1.65 B | |||
| EBITDA | 475.4 M | |||
| Cash And Equivalents | 629.3 M | |||
| Cash Per Share | 4.78 X | |||
| Total Debt | 253.9 M | |||
| Debt To Equity | 0.15 % | |||
| Book Value Per Share | 12.81 X | |||
| Cash Flow From Operations | 376.5 M | |||
| Earnings Per Share | 1.53 X | |||
| Total Asset | 2.47 B | |||
| Retained Earnings | 304 M | |||
| Current Asset | 543 M | |||
| Current Liabilities | 251 M | |||
About CochLear Performance
Evaluating CochLear's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CochLear has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CochLear has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.Things to note about CochLear ADR performance evaluation
Checking the ongoing alerts about CochLear for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CochLear ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CochLear ADR generated a negative expected return over the last 90 days |
- Analyzing CochLear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CochLear's stock is overvalued or undervalued compared to its peers.
- Examining CochLear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CochLear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CochLear's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CochLear's pink sheet. These opinions can provide insight into CochLear's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.